BioNTech Maintains Full-Year Revenue Outlook Despite Surprise Quarterly Sales Decline
In This Article:
BioNTech (BNTX) on Monday reiterated its full-year revenue outlook despite reporting an unexpected d
Upgrade to read this MT Newswires article and get so much more.
A Silver or Gold subscription plan is required to access premium news articles.